2 Matching Annotations
  1. Aug 2022
  2. www.biorxiv.org www.biorxiv.org
    Antibody Evasion Properties of SARS-CoV-2 Omicron Sublineages
    1
    1. jackiekrauss 29 Aug 2022

      Iketani, S., Liu, L., Guo, Y., Liu, L., Huang, Y., Wang, M., Luo, Y., Yu, J., Yin, M. T., Sobieszczyk, M. E., Huang, Y., Wang, H. H., Sheng, Z., & Ho, D. D. (2022). Antibody Evasion Properties of SARS-CoV-2 Omicron Sublineages (p. 2022.02.07.479306). bioRxiv. https://doi.org/10.1101/2022.02.07.479306

      is:preprint lang:en COVID-19 Omicron mutation spike glycoprotein antibody evasion prevalence unique spike mutation antigenic characterization sublineage mRNA vaccine antigenically equidistant efficacy resistance monoclonal antibody therapy
    Visit annotations in context

    Tags

    Annotators

    URL

    biorxiv.org/content/10.1101/2022.02.07.479306v1
  3. Jun 2021
  4. www.bmj.com www.bmj.com
    Covid-19: variants and vaccination
    1
    1. sophia.sterckx 28 Jun 2021

      Darby, Alistair C., and Julian A. Hiscox. ‘Covid-19: Variants and Vaccination’. BMJ 372 (23 March 2021): n771. https://doi.org/10.1136/bmj.n771.

      is:article lang:en COVID-19 variants vaccination vaccine covid vaccine emergency use authorisation national rollout vaccine function glycoprotein misconseption mutation variant
    Visit annotations in context

    Tags

    Annotators

    URL

    bmj.com/content/372/bmj.n771